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Abstract: Two organic fluorophores, fluorescein (F) and rhodamine B (Rd), were entrapped in calcium phosphate
nanoparticles. The as-obtained nanoparticles can be used for biological release applications. For this aim, calcium
phosphate nanoparticles were synthesized using the precipitation method. Structural analysis of these nanoparticles was
performed using XRD, FTIR, and Raman spectroscopy, confirming that the synthesized nanoparticles were hydroxyapatite. TEM and SEM analyses demonstrated that these nanoparticles had a size of 20 nm and a well-defined morphology.
F and Rd (about 0.5 wt.%) were entrapped in these nanoparticles and their release, as a function of time, was studied
via UV-Vis spectroscopy. The obtained results showed that the release of both fluorophores was progressive over time.
The trapping efficiencies of the fluorophores were 67.15% and 90.76% for F and Rd, respectively.
Key words: Calcium phosphate nanoparticles, slow release, entrapment, organic fluorophores

1. Introduction
Calcium phosphate is one of the most important inorganic minerals in nature and it plays an essential role in
our daily lives [1]. As an inorganic mineral, it represents the most indispensable constituent of human bones
and teeth, and it is necessary in the function of nerves, cells, muscles, and bones. Calcium phosphate has a
very wide range of applications due to its excellent biodegradability, bioresorbability, and osteoconductivity
[2,3]. For instance, calcium phosphates are used as ocular implants allowing eye movement [4], nanosystems for
photodynamic therapy, contrast agents for multimodal imaging [5], drug delivery systems [6], vaccine adjuvants,
and antifungal agents [3]. Calcium phosphates are also present in the manufacturing of biosensors [7] and have
great attraction for binding with active substances, namely proteins, antigens, vaccines, and immunogens [8,9].
Under specific conditions, including temperature, humidity, and the presence of impurities, biological
calcium phosphates exist in different aspects and morphology [10]. The forms of calcium phosphate currently
applicable in the biomedical field are hydroxyapatite (HAP), amorphous calcium phosphate (ACP), tricalcium
phosphate (TCP), monocalcium phosphate monohydrate, biphasic calcium phosphate, and mixtures thereof.
Of these forms, HAP remains the most stable, least soluble, and most versatile material for nanomedicine. It is
the most appropriate biomedical material, given its unique physicochemical properties. Like other formulations,
HAP can be treated in dense or porous bulk form and as powders, granules, scaffolding, or coatings [11].
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For drug delivery systems and absorbable scaffolds, in most cases, the administration and monitoring of
molecules alone cannot succeed. For this reason, many studies on calcium phosphate nanoparticles as carriers
have been conducted [12], in which they protect active substances, prevent their degradation, help them to
overcome physical barriers, and increase their selectivity. The desired properties of such nanoparticles strongly
depend on their application and target tissue. The most important parameter is particle size. Particles smaller
than 100 nm are hardly recognized by the immune system and can be easily taken up by cells [13].
For imaging applications, calcium phosphate nanoparticles can be used as fluorescent probes after doping
with lanthanides [14–18] or surface functionalization with organic dyes [13,19–22]. Several studies have reported
the use of fluorescein (F) and its derivatives. From these studies, F is considered an important fluorescent
marker or probe that can be used for analyte detection and optical imaging due to characteristics such as its
high emission peak intensity, high molar absorption coefficients, and quantum yields in aqueous media [23,24].
Moreover, rhodamine B (Rd) has attracted considerable attention as a marker due to its spectral properties in
solution. To determine the quantum yields of fluorescence, Rd is often used as a standard [25]. It is also used as
an active medium for tunable lasers [26]. Fluorescent Off/On sensors based on Rd are characterized by very high
sensitivity and selectivity for the detection of changes in metal ions. It could detect them in biological systems
because it is pH-independent and could recognize ions under physiological conditions. It has been successfully
used for fluorescence imaging in living cells [27].
Within this context, calcium phosphate nanoparticles were synthesized herein using the precipitation
method. Disodium hydrogen phosphate dehydrate and calcium chloride were used as the main precursors.
The chemical structure of the obtained nanoparticles was studied via Raman, FTIR, and XRD spectroscopy.
Their size and morphology were studied by TEM/SEM microscopy. Next, these as-obtained HAP nanoparticles
(nano-HAP) were used to trap 2 types of fluorophores, F and Rd (about 0.5% by weight fluorophore), in order
to study their release properties. The trapping efficiency was tested using UV-Vis spectroscopy. The release
studies were performed as a function of time and the release efficiency for each fluorophore was calculated.
2. Materials and methods
2.1. Chemicals and materials
Disodium hydrogen phosphate dehydrate (Na 2 HPO 4 .2H 2 O, 177.99 g/mol), calcium chloride (CaCl 2 , 110.98
g/mol), sodium dodecyl sulfate (SDS) (CH 3 (CH 2 )11 OSO 3 Na, 288.38 g/mol), absolute ethanol (CH 3 CH 2 OH,
≥99.89%), and ultrapure water (18.02 g/mol) were all purchased commercially from Sigma-Aldrich (St. Louis,
MO, USA). All reagents used in the experiments were of analytical quality.
2.2. Synthesis of calcium phosphate nanoparticles (nano-HAP)
The crystalline nanoparticles of the calcium phosphate (nano-HAP) were synthesized using the precipitation
method. Na 2 HPO 4 solution (0.3 M; 60 mL) was added dropwise to 600 mL of a CaCl 2 (0.05 M) solution
that contained SDS (9 ×10 −4 mol/L). SDS was added as a dispersant to avoid nanoparticle agglomeration
during synthesis. According to the literature, to have nanoparticles with such properties in terms of size and
morphology using the coprecipitation method, it is necessary to maintain the pH at a basic level of about 10.0
±0.5 [28]. For this aim, a dilute ammonia solution (1 mol/L) was added. Next, the solution was stirred for 24 h
at room temperature. The obtained suspension was first washed 3 times with ethanol and ultrapure water, then
centrifuged (12,000 rpm) for 15 min and heated at 150 °C for 24 h to obtain the crystalline phase of nano-HAP
and remove the ammonium ions remaining in the final product [29].
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2.3. Entrapment of fluorophores in calcium phosphate nanoparticles
During the synthesis of nano-HAP, the fluorophores were added to a CaCl 2 solution (about 0.5 wt.%), resulting
in the entrapment of F and Rd (Figure 1) by calcium phosphate nanoparticles, and then the suspension was
heated at 150 °C for 24 h. The obtained fluorescent calcium phosphate nanoparticles were named nano-HAP-F
and nano-HAP-Rd.
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Figure 1. Chemical structure of F (left) and Rd (right).

2.4. Study of fluorophore release
The study of the release of Rd from nano-HAP-Rd and F from nano-HAP-F was performed in 4 mL of water
and in a mixture of water (3/4 mL) + ethanol (1/4 mL), respectively. In both studies, the solution was added
to 21 mg of fluorescent calcium phosphate nanoparticles.
The study of the release was conducted within a leaching time range of 5 min to 24 h for nano-HAP-F and
5 min to 4 days for nano-HAP-Rd. The solution was filtered, placed under a UV-Vis lamp, and later analyzed
via UV-Vis spectroscopy in order to determine the released concentration over time.
2.5. Characterization techniques
2.5.1. X-ray diffraction
In order to determine the nature of synthesized nanoparticles phase, the samples were analyzed via XRD.
Diffraction data were collected at room temperature on a D2 PHASER diffractometer (Billerica, MA, USA),with
Bragg–Brentano geometry using CuK α radiation ( λ

= 1.5406 Å) at 30 kV and 10 mA. The patterns were

scanned through 0.01 (2 θ) steps in the 2 θ range of 10°to 80°.
The sample preparation was done as follows: 400 mg of powder was placed on the specimen holder and
lightly pressed with a glass slide, and then the excess powder was removed. LaB 6 powder was used as the
standard.
2.5.2. FTIR spectroscopy
To determine the chemical structure of the nanoparticles, the sample was analyzed via FTIR spectroscopy. IR
spectra were recorded between 400 and 4000 cm −1 with a Nicolet 205 FTIR spectrometer (Waltham, MA,
USA).
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A homogeneous mixture of approximately 1% of the sample powder/KBr was ground and deposited in a
mold. It was then subjected to very high pressure in a hydraulic press to obtain powder/KBr pellet.
2.5.3. Raman spectroscopy
Raman spectroscopy was performed in order to confirm the chemical structure of nano-HAP. Raman spectra
were obtained on a Labram 010 spectrometer (Dilor; Horiba Scientific, Kyoto, Japan), using the 514.5-nm green
line of an argon laser as an excitation source. The sample was step-scanned at 1 cm −1 resolution between 500
and 2000 cm −1 .
2.5.4. Transmission electron microscopy
TEM was performed on a Hitachi H7650 microscope (Tokyo, Japan) at an accelerating voltage of 80 to 120 kV.
Measurements were obtained using high-resolution mode for magnifications ranging from 4000 to 600,000.
2.5.5. Scanning electron microscopy
The SEM micrographs were recorded using a Hirox SH-4000 M microscope (Tokyo, Japan) operating under high
vacuum from 5 kV to 30 kV, and using a secondary electron detector (SE detector & BSE detector, multimode).
The holder and samples were placed in the metallizer chamber, where a vacuum was created.
2.5.6. UV-Vis spectroscopy
The entrapment efficiencies of nano-HAP-F and nano-HAP-Rd were determined by UV-Vis solid spectroscopy. A
Shimadzu UV-VIS-NIR spectrophotometer (Kyoto, Japan) was used to measure the spectrum of light absorption
at a wavelength ranging from 200 to 2400 nm.
The entrapment efficiency was confirmed by UV-Vis spectroscopy. A UV-1800 spectrophotometer at a
resolution of 1 nm, which was designed in accordance with the European Pharmacopoeia (CFR Part 11), was
used.
The release yield (Rt.%) of the 2 fluorophores was calculated by measuring the fluorophore content in the
supernatant after centrifugation and filtration, and the amount entrapped by nano-HAP was deduced according
to the following formula [30]:
Rt (%) =

mi (Fl) −ms(Fl)
×100,
mi(Fl)

where mi(Fl) is the initial fluorophore mass and ms(Fl) is the supernatant fluorophore mass.
3. Results and discussion
3.1. Characterization of calcium phosphate nanoparticles (nano-HAP)
The synthesized calcium phosphate nanoparticles were examined by XRD, Raman, and FTIR. The results
showed that the nanoparticles had a good crystalline HAP structure. According to the XRD diffractogram
(Figure 2), the calcium phosphate phases, such as ACP, octacalcium phosphate, TCP, and dicalcium phosphate
dehydrate, were not detected, which allowed the conclusion that the main composition of nano-HAP was the
crystalline phase of the calcium phosphate (HAP). The nano-HAP had the typical XRD HAP profile and
all of the diffraction peaks could be assigned according to the standard model (JCPDS09-0432). The FTIR
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Figure 2. Nano-HAP XRD diffractogram.

spectrum of calcium phosphate nanoparticles (nano-HAP) (Figure 3a) showed the triple degenerate asymmetric
−1
stretching and bending vibrations of PO 3−
[31].
4 , which were observed only in the HAP, at 1093 and 565 cm

This experimental result confirmed the crystallized phase of the HAP. The CO 2−
peaks at 1419 and 871
3
cm −1 were due to the presence of some carbonate ions in nano-HAP. The incorporation of carbonates is a
common phenomenon during the formation of biological apatites [12,32]. The peak at 3568 cm −1 represented
the structural -OH group of HAPs. The peaks at 3427 and 1645 cm −1 corresponded to the remaining water.
The broad peak around 1600 cm −1 could be attributed to the C-C bond of the SDS detected in the sample,
which showed that there were traces of residual additives. The results were confirmed by Raman spectroscopy
(Figure 3b), where the characteristic bands of the PO 3−
ion were located as follows: ν1 at 991 cm −1 , ν2 at
4
564 cm −1 , ν3 at 1080 cm −1 , and ν4 at 563 cm −1 [33]. Furthermore, the characteristic bands of the OH group
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Figure 3. FTIR (a) and Raman (b) spectra of nano-HAP.
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The morphology and size of nano-HAP were characterized by TEM and SEM. The TEM observations
clearly showed that the nano-HAP particles had the morphology of grains with an approximate diameter of 20
nm (Figure 4a). The SEM observations confirmed that the particles had a uniform size, and were nanodispersed
with well-defined morphology (Figure 4b).
The SEM images showed a remarkable change in morphology between the raw nanoparticles and those
that trapped the fluorophores. In the case of nano-HAP (Figure 4b), nanoparticles were presented as isolated
grains with well-defined nanostructured morphology. Regarding nano-HAP-F (Figure 4c) and nano-HAP-Rd
(Figure 4d), it was observed that the fluorophores had been interposed between the grains of nano-HAP.

Figure 4. TEM image of nano-HAP (a). SEM images of nano-HAP (b), nano-HAP-F (c), and nano-HAP-Rd (d).

3.2. Characterization of nano-HAP-F and nano-HAP-Rd
Characterization of the raw nanoparticles and nanoparticles entrapping F and Rd by FTIR were performed.
The spectra of nano-HAP-F (Figure 5a) and nano-HAP-Rd (Figure 5b) were characterized by the appearance
of an intense and wide band between 3790 and 3017 cm −1 that was associated with the hydrogen bond (interand intra-) of the OH-O group. A precise assignment of the OH stretching mode was not clear because a
very intense wide band was observed in the OH region of the spectrum due to the presence of H 2 O. The 2
bands that appeared at 2925 cm −1 and 2825 cm −1 for nano-HAP-F and nano-HAP-Rd can be attributed to
the aliphatic CH vibration stretches of F and Rd. The bands that appeared at 1200–1000 cm −1 were attributed
to the C-O stretching vibrations in alcohols and phenols, confirming the presence of the OH group of F (Figure
5a). The band at 1645 cm −1 was due to the C =C and the C =N elongation band of nano-HAP-Rd (Figure
5b). Medium intensity bands between 1020 and 1220 cm −1 were attributed to the C-N band of nano-HAP-Rd.
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The remarkable difference in intensity between the spectra of nano-HAP-F and nano-HAP-Rd was due to the
presence of the OH and C =O groups, confirming the presence of F in nano-HAP-F.
The chemical composition was confirmed by Raman spectroscopy (Figure 6), where the characteristic
bands of the PO 3−
ion appeared in all 3 spectra (raw nano-HAP, nano-HAP-F, and nano-HAP-Rd) as ν1 at
4
991 cm −1 , ν2 at 564 cm −1 , ν3 at 1080 cm −1 , and ν4 at 563 cm −1 . The characteristic bands of the OH group

991

were located at 624 cm −1 and 371 cm −1 . The results were in agreement with those of the FTIR spectroscopy.
The difference in the peak intensity was remarkable for the results obtained by Raman spectroscopy due to the
presence of the OH and C =O groups characterizing F in nano-HAP-F and the C =O group characterizing Rd
in nano-HAP-Rd.
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Figure 5. FTIR spectra of nano-HAP-F (a) and nanoHAP-Rd (b).
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3.3. Fluorescence of nano-HAP-F and nano-HAP-Rd
The fluorescence of nano-HAP, nano-HAP-F, and nano-HAP-Rd were observed under a UV lamp.
As shown in Figure 7, when the samples were excited under UV light (365 nm), it was clearly observed
that nano-HAP had very low fluorescence (Figure 7a) when compared to those trapping fluorophores. The
green (Figure 7b) and pink (Figure 7c) colors appeared only for nanoparticles trapping F and Rd, respectively.
Nano-HAP, nano-HAP-F, and nano-HAP-Rd were analyzed via UV-Vis solid spectroscopy. The maximum absorption wavelengths were 494 nm and 554 nm, which corresponded to those of F and Rd, respectively.
Figure 8 shows that the nano-HAP-F (Figure 8a) and nano-HAP-Rd (Figure 8b) spectra were more intense
when compared to that of nano-HAP. The entrapment efficiency of F and Rd were about 65.17% and 90.76%,
respectively. This efficiency was confirmed by UV-Vis spectroscopy by measuring the fluorophore content in
the supernatant after centrifugation and filtration and then deducting the amount encapsulated by nano-HAP.

3.4. Study of fluorophore release (F and Rd)
To follow the kinetics of the release of F and Rd as a function of time, we first applied UV light. Next, the
release of F and Rd was studied using UV-Vis spectroscopy.
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Figure 7. Photographs of nano-HAP (a), nano-HAP-F (b), and nano-HAP-Rd (c) under a UV lamp.

Ab sor b a nce (Log (1/R)

494

Absor ba nce (L og(1/R ))

NanoHAP
NanoHAP-F

400

Wavlength (nm)

600

554

(b)

(a)

NanoHAP
NanoHAP-Rd

400

Wavelength(nm)

600

Figure 8. UV-Vis spectra of nano-HAP-F (a) and nano-HAP-Rd (b).

3.4.1. Observations under UV light
As illustrated in Figure 9, different colors were obtained by entrapping with different fluorophores. Samples were
excited with UV light (365 nm). The calcium phosphate nanoparticles entrapping F emitted green light (Figure
9a) and the particles entrapping Rd emitted pink light (Figure 9b). The shade of the solution became darker
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over time, indicating that the fluorophore release prolonged over time. The prolonged release was confirmed by
UV-Vis spectroscopy.

Figure 9. Observation of nano-HAP-F (a) and nano-HAP-Rd (b) under UV-light during the release of fluorophores as
a function of time.

3.4.2. UV-Vis analysis
The release of fluorophores was also studied via UV-Vis spectroscopy. Within a leaching time range of 5 min to
24 h for nano-HAP-F and 5 min to 4 days for nano-HAP-Rd, the maximum absorption wavelengths were 494
nm and 554 nm, respectively.
The release efficiencies of F (Figure 10a) and Rd (Figure 10b) showed similar diffusional kinetic profiles,
where the amount of released fluorophores increased as a function of time. As can be seen, the release of Rd
was more sustained than that of F. This difference may have been due to the high solubility of Rd in water
when compared to that of F.
3.5. Conclusions
To summarize, HAP nanoparticles were successfully prepared via the precipitation method. The average nanoHAP size evaluated from the TEM observations showed a proximate value of 20 nm. Nano-HAPs of such
size and morphology are of interest for many applications for biological purposes, including optical imaging
and photodynamic therapy. The prolonged release of fluorophores entrapped in nano-HAP will provide an
interesting view of the roles of the crystalline phase of calcium phosphates for future clinical applications as
ideal biomedical materials. Future work should focus on other ways to control the release of organic substances
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Figure 10. Release profile of (a) F and (b) Rd from nano-HAP-F and nano-HAP-Rd, respectively, over time, as
measured by UV-Vis spectrophotometry.

from these nanoparticles and the possibility of extending their release. In terms of size and trapping efficiency,
and release of an external agent, these results were comparable to the findings of similar work, but considerably
more effective than those synthesized by other groups [36–42].
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